Skip to main content

KC 15 (Potassium Citrate Extended-Release 15 mEq (1620 mg))

Pill with imprint KC 15 is Yellow, Elliptical / Oval and has been identified as Potassium Citrate Extended-Release 15 mEq (1620 mg). It is supplied by Bionpharma Inc..

Potassium citrate is used in the treatment of renal tubular acidosis; nephrolithiasis and belongs to the drug class urinary pH modifiers. Risk cannot be ruled out during pregnancy. Potassium citrate 15 mEq (1620 mg) is not a controlled substance under the Controlled Substances Act (CSA).

Images for KC 15

Potassium Citrate Extended-Release

Imprint
KC 15
Strength
15 mEq (1620 mg)
Color
Yellow
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Urinary ph modifiers
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Bionpharma Inc.
National Drug Code (NDC)
69452-0194

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.